Reboxetine use in the treatment of attention-deficit/hyperactivity disorder.

Cak, Halime T; Cetin, Füsun Cuhadaroglu

Cak, Halime T; Cetin, Füsun Cuhadaroglu.

J Child Adolesc Psychopharmacol ; 16(6): 803-4, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17201625

Subject(s)

Antidepressive Agents/therapeutic use; Attention Deficit Disorder with Hyperactivity/drug therapy; Morpholines/therapeutic use; Adolescent; Antidepressive Agents/adverse effects; Antidepressive Agents, Tricyclic/therapeutic use; Attention Deficit Disorder with Hyperactivity/psychology; Central Nervous System Stimulants/adverse effects; Central Nervous System Stimulants/therapeutic use; Child; Female; Humans; Imipramine/therapeutic use; Male; Methylphenidate/adverse effects; Methylphenidate/therapeutic use; Morpholines/adverse effects; Reboxetine

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Morpholines / Antidepressive Agents Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2006 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links